Whales with a lot of money to spend have taken a noticeably bullish stance on Datadog. Looking at options history for Datadog DDOG we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 30% ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Arista Networks. Looking at options history for Arista Networks ANET we detected 23 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish ...

Shell plc ( the 'Company' ) announces that on 2 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:

Sydney, Australia, May 02, 2025 ( GLOBE NEWSWIRE ) -- Modern users can acquire cryptocurrency through cloud mining, an effortless method that avoids buying expensive machines and electricity costs.

BETHLEHEM, Pa., May 02, 2025 ( GLOBE NEWSWIRE ) -- Embassy Bank For the Lehigh Valley is proud to announce that it has once again been named Best Bank & Mortgage Company by the Who's Who in Business survey, featured in Lehigh Valley Style magazine.

Roku reported Q1 revenue growth of 16% Y/Y, adj. EBITDA growth of 37% Y/Y. The company's guidance reflects a deceleration in revenue growth in Q2. Today's manic market swings are creating the perfect setup for Matt's next volatility trade. Get his next trade alert for free, right here.

SINGAPORE, May 02, 2025 ( GLOBE NEWSWIRE ) -- On May 1, 2025, WEEX, the world's leading cryptocurrency trading platform, made an impressive appearance at TOKEN2049 in Dubai.

LendingTree shares fall premarket despite adjusted EPS beating estimates; revenue misses and adjusted EBITDA margin contracted. The company slashes its FY25 revenue outlook, although Q2 revenue guidance was near estimates. Feel unsure about the market's next move?

Shell shares rose premarket despite revenue missing estimates; adjusted earnings increased significantly Q/Q, but adjusted EPS missed. The company announced a new $3.5 billion share buyback program and declared a dividend of $0.358 per share.

KALOS and LOGOS trials with 4,400 patients showed Breztri improved lung function over dual ICS/LABA therapies. No new safety concerns were found in Breztri Phase 3 asthma trials; all primary endpoints were met.